» Articles » PMID: 33219847

Skeletal Muscle Mass and Sarcopenia Can Be Determined with 1.5-T and 3-T Neck MRI Scans, in the Event That No Neck CT Scan is Performed

Overview
Journal Eur Radiol
Specialty Radiology
Date 2020 Nov 21
PMID 33219847
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Cross-sectional area (CSA) measurements of the neck musculature at the level of third cervical vertebra (C3) on CT scans are used to diagnose radiological sarcopenia, which is related to multiple adverse outcomes in head and neck cancer (HNC) patients. Alternatively, these assessments are performed with neck MRI, which has not been validated so far. For that, the objective was to evaluate whether skeletal muscle mass and sarcopenia can be assessed on neck MRI scans.

Methods: HNC patients were included between November 2014 and November 2018 from a prospective data-biobank. CSAs of the neck musculature at the C3 level were measured on CT (n = 125) and MRI neck scans (n = 92 on 1.5-T, n = 33 on 3-T). Measurements were converted into skeletal muscle index (SMI), and sarcopenia was defined (SMI < 43.2 cm/m). Pearson correlation coefficients, Bland-Altman plots, McNemar test, Cohen's kappa coefficients, and interclass correlation coefficients (ICCs) were estimated.

Results: CT and MRI correlated highly on CSA and SMI (r = 0.958-0.998, p < 0.001). The Bland-Altman plots showed a nihil mean ΔSMI (- 0.13-0.44 cm/m). There was no significant difference between CT and MRI in diagnosing sarcopenia (McNemar, p = 0.5-1.0). Agreement on sarcopenia diagnosis was good with κ = 0.956-0.978 and κ = 0.870-0.933, for 1.5-T and 3-T respectively. Observer ICCs in MRI were excellent. In general, T2-weighted images had the best correlation and agreement with CT.

Conclusions: Skeletal muscle mass and sarcopenia can interchangeably be assessed on CT and 1.5-T and 3-T MRI neck scans. This allows future clinical outcome assessment during treatment irrespective of used modality.

Key Points: • Screening for low amount of skeletal muscle mass is usually measured on neck CT scans and is highly clinical relevant as it is related to multiple adverse outcomes in head and neck cancer patients. • We found that skeletal muscle mass and sarcopenia determined on CT and 1.5-T and 3-T MRI neck scans at the C3 level can be used interchangeably. • When CT imaging of the neck is missing for skeletal muscle mass analysis, patients can be assessed with 1.5-T or 3-T neck MRIs.

Citing Articles

Impact of magnetic resonance imaging-defined sarcopenia on prognosis in patients with locally advanced nasopharyngeal carcinoma.

Yang Y, Gao Y, Luo Y, Liu W, Xie P, Huang L Discov Oncol. 2025; 16(1):141.

PMID: 39923220 PMC: 11807948. DOI: 10.1007/s12672-025-01925-5.


Identifying threshold of CT-defined muscle loss after radiotherapy for survival in oral cavity cancer using machine learning.

Lee J, Lin J, Lin W, Jan Y, Leu Y, Chen Y Eur Radiol. 2024; .

PMID: 39706923 DOI: 10.1007/s00330-024-11303-4.


Imaging-based evaluation of cervical muscle mass and 6-month survival in males with hypopharyngeal carcinoma.

Lauren J, Keski-Santti H, Makitie A, Arponen O Acta Oncol. 2024; 63:950-957.

PMID: 39688227 PMC: 11681277. DOI: 10.2340/1651-226X.2024.40481.


How do patients with head and neck cancer and low skeletal muscle mass experience cisplatin-based chemoradiotherapy? A qualitative study.

Schaeffers A, van Beers M, Devriese L, Klomp F, Westerink-van den Brink C, Smid E Support Care Cancer. 2024; 32(11):751.

PMID: 39467871 PMC: 11519173. DOI: 10.1007/s00520-024-08950-0.


The cross-sectional area of gluteal muscle on multiaxial CT scan as a predictor for diagnosing sarcopenia in patients with degenerative lumbar disease.

Ham D, Lee J, Choi G, Kwon B, Song K Eur Spine J. 2024; 33(10):3857-3864.

PMID: 39198285 DOI: 10.1007/s00586-024-08452-x.


References
1.
Zwart A, van der Hoorn A, van Ooijen P, Steenbakkers R, de Bock G, Halmos G . CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer. J Cachexia Sarcopenia Muscle. 2019; 10(5):1060-1069. PMC: 6818448. DOI: 10.1002/jcsm.12443. View

2.
Hua X, Liu S, Liao J, Wen W, Long Z, Lu Z . When the Loss Costs Too Much: A Systematic Review and Meta-Analysis of Sarcopenia in Head and Neck Cancer. Front Oncol. 2020; 9:1561. PMC: 7012991. DOI: 10.3389/fonc.2019.01561. View

3.
Chung N, Ting L, Hsu W, Lui L, Wang P . Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head Neck. 2004; 26(3):241-6. DOI: 10.1002/hed.10378. View

4.
Poon P, Tsang V, Munk P . Tumour extent and T stage of nasopharyngeal carcinoma: a comparison of magnetic resonance imaging and computed tomographic findings. Can Assoc Radiol J. 2000; 51(5):287-95, quiz 286. View

5.
Engstrom C, Loeb G, Reid J, FORREST W, Avruch L . Morphometry of the human thigh muscles. A comparison between anatomical sections and computer tomographic and magnetic resonance images. J Anat. 1991; 176:139-56. PMC: 1260321. View